On Thursday, June 23rd, CDC’s Advisory Committee on Immunization Practices (ACIP) expanded the recommendations for the use of Moderna COVID-19 vaccines to include children ages 6 through 17 years. They recommended Moderna’s COVID-19 vaccines in a 2-dose primary series for children ages 6 through 17 years and in a 3-dose primary series for children ages 6 through 17 years who are moderately or severely immunocompromised. CDC Director Dr. Rochelle Walensky endorsed that recommendation and released a statement.
Moderna’s COVID-19 vaccines remain recommended for use for people 18 years of age and older as a primary series and as boosters and for children ages 6 months through 5 years as a primary series.
Moderna’s COVID-19 vaccines’ safety and effectiveness have been confirmed by clinical studies and by the millions of people who have already received them. As occurs for all vaccines—including all COVID-19 vaccines—safety monitoring will continue in all ages for whom Moderna vaccines are recommended and authorized.
CDC recommends everyone ages 6 months and older get vaccinated against COVID-19. Everyone 5 years and older should also get a COVID-19 booster, if eligible. To learn if and when your child or teen can get boosters to stay up to date with their COVID-19 vaccines, use CDC’s COVID-19 booster tool.
Below is a list of resources and upcoming informational activities related to the recommendations:
- Updated Interim Clinical Considerations
- Updated web pages for the public including:
- Moderna COVID-19 Vaccine Overview and Safety
- Stay Up to Date with Your COVID-19 Vaccines
- COVID-19 Vaccines for People who are Moderately or Severely Immunocompromised
- Post-ACIP Partner call– June 27, 2022, 2:00 – 3:00 ET
- CDC COVID-19 All-STLT Update Call– July 18, 2022
Skip to content